The managing director of litigation funder Vannin Capital lost a battle to dismiss a cross claim brought against him by rival LCM in a case alleging LCM has misapplied funds in its trust.
The litigation funder at the centre of a challenge by Westpac to the Federal Court’s power to make common fund orders faced a fiery judge in a tense exchange Friday, after it revealed it was weighing a bid to pause a class action against the bank until after the appeal.
A Federal Court judge on Friday called a request for particulars by Qantas “ridiculous”, during the first hearing in a case brought by mechanics alleging they weren’t pay allowances owed while working on assignment in Los Angeles.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
ASIC has successfully opposed a Federal Court judge’s push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
PriceWaterHouse Coopers has received the green light to launch court action to pursue its cross claims against failed educational training company Vocation.
Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
The ACCC secured $120.1 million in competition penalties in the 2017-18 financial year, including a record $46 million fine, and with a strong influx of immunity applications throughout the year, the cartel cop shows no signs of slowing down.
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.